Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Strang

Showing results (131-140 of 301) with videos related to

Pageof 31
Sort By:
Addiction Biology|March 20, 2002
A Short Alcohol Withdrawal Scale (SAWS): development and psychometric propertiesMichael Gossop, Francis Keaney, Duncan Stewart, et al.
Addiction (Abingdon, England)|September 23, 2021
Abuse-deterrent extended-release oxycodone and risk of opioid-related harmTapio Paljarvi, John Strang, Patrick D Quinn, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patientsNicholas Lintzeris, Timothy B Mitchell, Alyson Bond, et al.
Drug and Alcohol Review|March 18, 2025
Addiction specialists' perspectives on digital contingency management and its role within UK drug and alcohol services: A qualitative explorationCarol-Ann Getty, Nicola Metrebian, Joanne Neale, et al.
Addiction Biology|May 15, 2003
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatmentsTracy Beswick, David Best, Sian Rees, et al.
Drug and Alcohol Dependence|July 13, 2007
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patientsNicholas Lintzeris, Timothy B Mitchell, Alyson J Bond, et al.
Addiction (Abingdon, England)|May 17, 2007
Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005John Strang, Victoria Manning, Soraya Mayet, et al.
The American Journal on Addictions|September 25, 2003
The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trialTracy Beswick, David Best, Jenny Bearn, et al.
Drug and Alcohol Review|December 20, 2005
Cannabis use in adolescents: the impact of risk and protective factors and social functioningDavid Best, Samantha Gross, Victoria Manning, et al.
Pageof 31

Showing results (131-140 of 301) with videos related to

Sort By:
Pageof 31
Addiction Biology|March 20, 2002
A Short Alcohol Withdrawal Scale (SAWS): development and psychometric propertiesMichael Gossop, Francis Keaney, Duncan Stewart, et al.
Addiction (Abingdon, England)|September 23, 2021
Abuse-deterrent extended-release oxycodone and risk of opioid-related harmTapio Paljarvi, John Strang, Patrick D Quinn, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patientsNicholas Lintzeris, Timothy B Mitchell, Alyson Bond, et al.
Drug and Alcohol Review|March 18, 2025
Addiction specialists' perspectives on digital contingency management and its role within UK drug and alcohol services: A qualitative explorationCarol-Ann Getty, Nicola Metrebian, Joanne Neale, et al.
Addiction Biology|May 15, 2003
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatmentsTracy Beswick, David Best, Sian Rees, et al.
Drug and Alcohol Dependence|July 13, 2007
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patientsNicholas Lintzeris, Timothy B Mitchell, Alyson J Bond, et al.
Addiction (Abingdon, England)|May 17, 2007
Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005John Strang, Victoria Manning, Soraya Mayet, et al.
The American Journal on Addictions|September 25, 2003
The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trialTracy Beswick, David Best, Jenny Bearn, et al.
Drug and Alcohol Review|December 20, 2005
Cannabis use in adolescents: the impact of risk and protective factors and social functioningDavid Best, Samantha Gross, Victoria Manning, et al.
Pageof 31